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Background/Aims: Surgeons must be aware of risk factors 
for strictures before performing endoscopic submucosal dis-
section (ESD), to enable early interventions to prevent severe 
strictures. Methods: This study was a single-center retro-
spective study. We reviewed the clinical data of patients who 
has undergone gastric ESD from January 2007 to December 
2012. Results: Among the 3,819 patients who had under-
gone gastric ESD, 11 patients (7.2%) developed pyloric stric-
tures and received successful endoscopic balloon dilation. 
Significant differences were noted between the patients with-
out and with post-ESD strictures for pretreatment of antral 
or pyloric deformities (46.4% vs 81.8%), the proportion of ex-
tension to the lumen circumference (>3/4, 9.4% vs 54.5%), 
the longitudinal extent of mucosal defects (27.9±10.1 mm 
vs 51.5±10.8 mm), and post-ESD bleeding (2.9% vs 27.3%). 
Multivariate analysis revealed that pretreatment antral or 
pyloric deformities (odds ratio [OR], 30.53; 95% confidence 
interval [CI], 1.476 to 631.565; p=0.027), larger longitudinal 
extent of mucosal defects (OR, 1.20; 95% CI, 1.074 to 1.340; 
p=0.001), and circumferential extension of ≥3/4 (OR, 13.69; 
95% CI, 1.583 to 118.387; p=0.017) were independent risk 
factors for post-ESD stricture. Conclusions: Antral or pyloric 
deformities, sub-circumferential resection over more than 
75% of the circumference and greater longitudinal extent of 
mucosal defects are independent risk factors for post-ESD 
stricture. (Gut Liver 2016;10:757-763)
Key Words: Antral deformity; Pyloric deformity; Endoscopic 
submucosal dissection; Post-endoscopic submucosal dissec-
tion stricture 
INTRODUCTION
Endoscopic resection (ER) for gastric tumors is minimally 
invasive, respects the quality of life, and is similar in efficacy to 
surgery.1 Currently, endoscopic submucosal dissection (ESD) is 
established as standard treatment in patients with gastric tumor, 
including early gastric cancer (EGC) who have a negligible risk 
of lymph node metastasis.2-5 Because ER, and especially ESD, al-
lows en bloc resection, ER can ensure accurate histopathological 
examination and reduce the risk of local recurrence. 
Although the safety of ESD has been demonstrated, it is 
technically challenging and requires a well-trained endoscopist. 
ESD is also associated with massive bleeding, perforation, and 
stricture. Bleeding and perforation are the most common com-
plications and tend to occur during or within 24 to 48 hours 
after the procedure, whereas post-ESD strictures occur several 
weeks after intervention. Because post-ESD stricture can cause 
severe obstructive symptoms, including nausea, vomiting, dys-
phagia, and weight loss, awareness of the risk factors for post-
ESD stricture prior to the procedure is important so that early 
interventions, including endoscopic balloon dilatation and local 
steroid injection, can be performed. In previous studies, resected 
circumference, longitudinal diameter, and location of the lesion 
have been associated with post-ESD strictures.6,7 Among these, 
circumferential extension over 75% is a strong risk factor for 
post-ESD stricture.6,7 However, clinically, in the presence of an-
trum or pyloric deformity caused by ulcer scarring before ESD, 
post-ESD stricture occurs frequently, even if the circumferential 
extension is <75%. Therefore, we performed this study to inves-
tigate whether antral or pyloric deformity is a significant risk 
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factor for development of post-ESD stricture.
MATERIALS AND METHODS
1. Patients
This study is a single center, retrospective study. We ret-
rospectively reviewed a prospective database at Severance 
Hospital, Yonsei University College of Medicine, Seoul, Korea. 
From January 2007 to December 2012, a total 3,819 patients 
with 1,642 EGC and 1,747 adenoma underwent ESD. Of these, 
150 cases of gastric tumors were at the prepylorus or pylorus. 
Eleven of the 150 patients (7.3%) developed pyloric strictures. 
The median follow-up period was 22.3 months. After ESD, 
patients were followed in an outpatient clinic, and endoscopy 
was routinely performed 2 to 3 months later. In the presence of 
obstructive symptoms, EGD was performed earlier. All patients 
provided informed consent before undergoing the procedure, 
and the Institutional Review Board of Severance Hospital ap-
proved this study. 
2. ESD procedures
All ESDs were performed under conscious sedation that 
was achieved with intravenous midazolam and/or propofol. A 
standard single-channel endoscope (GIF-Q260J or GIF-H260Z; 
Olympus, Tokyo, Japan) was used. After identifying the target 
lesion, dots were marked circumferentially at about 5 mm lat-
eral to the margin of the lesion using a needle knife (KD-10Q; 
Olympus) or argon plasma coagulation (Erbe Elektromedizin, 
Tübingen, Germany). Epinephrine (1:10,000 dilution) was then 
injected into the submucosal layer using a 21-gauge needle to 
lift the lesion from the muscle layer. Circumferential mucosa 
was excised outside the dots, and an additional submucosal 
injection was made. Finally, direct dissection of the submucosal 
layer was performed using an insulated-tip knife (KD-610L; 
Olympus). Endoscopic hemostasis with specialized hemostatic 
forceps (FD-410LR; Olympus) was performed, as needed. 
3. Definitions
Prepyloric lesion was defined as any mucosal defect after 
ESD was located within 2 cm from the pylorus ring. Post-
ESD stricture was defined as a pyloric stricture that could not 
be traversed with a standard 1-cm endoscope. Patients were 
divided into two groups, namely those with or without a post-
ESD stricture. All patients with a post-ESD stricture underwent 
endoscopic balloon dilatation. Between the two groups, age, 
sex, concomitant disease, location of lesion and macroscopic 
type, depth of invasion, longitudinal extent of mucosal defect, 
resection range including the pyloric ring, and antral or pyloric 
deformity, were compared. Antral or pyloric deformity was de-
fined as a distortion or narrowing of antrum usually caused by 
peptic ulcer scarring or prominent folds.8 All endoscopic images 
were reviewed by two expert endoscopists and the presence of 
the antral or pyloric deformity was judged. We divided antral or 
pylorus deformity into two groups, distortion dominant or nar-
rowing dominant group. We defined distortion dominant type 
when the whole pylorus ring could not be seen in a forwarding 
endoscopic view because of severe distortion caused by promi-
nent folds or hypertrophy of the antral pyloric musculature in 
prepylorus (Fig. 1A). Narrowing dominant type was defined 
when antrum and prepylorus lesion became narrow abruptly 
toward pylorus ring caused by ulcer scarring or pyloric hyper-
trophy (Fig. 1B). The longitudinal extent of mucosal defect was 
investigated based on gross pathology reports of the resected 
specimen. Acute complications were defined as adverse events 
within 48 hours after ESD. Bleeding was defined as an event 
such as hematemesis or melena, and adverse event requiring 
transfusion or endoscopic hemostasis. Perforation included a 
definite gastric wall defect during ESD and microperforation 
diagnosed by free air in X-ray after ESD. An attending gastro-
enterologist noted the presence of antral or pyloric deformity 
before ESD. 
4. Treatment of post-ESD stricture patients
Patients with symptoms (nausea, vomiting, and dysphagia) 
caused by the pyloric stricture were treated by endoscopic bal-
loon dilation performed under endoscopic and fluoroscopic 
guidance by experienced endoscopists. All procedures were per-
formed under conscious sedation using intravenous midazolam 
Fig. 1. Endoscopic images of antral/
pyloric deformities. A high-grade 
dysplasia lesion was present in the 
distal antrum. (A) Distortion domi-
nant type: the whole pylorus ring 
could not be seen in the forward 
endoscopic view because of severe 
distortion of the prepylorus. (B) Nar-
rowing dominant type: the distal 
antrum and prepylorus lesion nar-
rowed abruptly toward the pylorus 
ring.
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and/or propofol. A forward-viewing esophagogastroduodeno-
scope (GIF-H260; Olympus) was inserted through the mouth, 
and a 12 to 15 mm, 15 to 18 mm, or 18 to 20-mm wire-guided 
balloon dilator (CRE Wire-Guided Balloon Dilatation Catheter; 
Boston Scientific, Marlborough, MA, USA) was inserted through 
the working channel of the endoscope. The balloon was ad-
vanced across the stricture and by injecting water under con-
trolled pressure, was dilated to progressively increase the diam-
eter of the stricture. The diameter size and ballooning time were 
determined by the endoscopist and depended on the endoscopic 
assessment of the luminal width. After deflation, the procedure 
was ended after examining the patency of the pylorus by ad-
ministering a contrast agent (Gastrografin; Bayer, Seoul, Korea) 
under fluoroscopy.
In addition, local triamcinolone acetonide (TCA) (50 mg/5 
mL; Dongkwang Pharmaceutical Co., Seoul, Korea) injection 
Table 1. Baseline Characteristics and Risk Factors for Post-ESD Stricture
Characteristic
Post-ESD stricture
Total (n=150) None (n=139) Present (n=11) p-value 
Age, yr 69.6±10.0 69.3±10.2 73.6±6.0 0.166
Sex 0.122
    Male 139 (92.7) 97 (69.8) 10 (90.9) 
    Female 11 (7.3) 42 (30.2) 1 (9.1) 
Concomitant disease
    Hypertension 60 (40.0) 55 (39.6) 5 (45.5) 0.701
    Diabetes mellitus 22 (14.7) 22 (15.8) 0 0.153
    Chronic renal failure 2 (1.3) 2 (1.4) 0 0.689
    Hepatitis 4 (2.7) 3 (2.2) 1 (9.1) 0.169
Location of lesion 0.548
    Lesser curvature 52 (34.7) 48 (34.5) 4 (36.4) 
    Anterior wall 50 (33.3) 48 (34.5) 2 (18.2) 
    Greater curvature 26 (17.3) 24 (17.3) 2 (18.2) 
    Posterior wall 22 (14.7) 19 (13.7) 3 (27.3) 
Lesion macroscopic type 1.000 
    Elevated 118 (78.7) 109 (78.4) 9 (81.8)
    Flat or depressed 32 (21.3) 30 (21.6) 2 (18.2)
Histology 0.741
    Adenoma 103 (68.7) 96 (69.1) 7 (63.6)
    Adenocarcinoma 47 (31.3) 43 (30.9) 4 (36.4)
        Well differentiated 30 (21.6) 3 (27.3)
        Moderately differentiated 9 (6.5) 1 (9.1)
        Poorly differentiated 0 0 
        Signet ring cell 1 (0.7) 0 
        Carcinoma in situ 3 (2.2) 0 
Depth of invasion 0.586
    Carcinoma in situ 3 (6.4) 3 (7.0) 0 
    Mucosal 38 (80.9) 35 (81.4) 3 (75.0)
    Submucosal 6 (12.8) 5 (11.6) 1 (16.7)
En bloc resection 130 (86.7) 122 (87.8) 8 (72.7) 0.166
Curative resection 135 (90.0) 127 (91.4) 8 (72.7) 0.082
Acute complication
    Bleeding 7 (4.7) 4 (2.9) 3 (27.3) 0.009
    Perforation 3 (2.0) 2 (1.4) 1 (9.1) 0.206
Data are presented as median±SD or number (%).
ESD, endoscopic submucosal dissection.
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was performed 1 to 2 days after ESD according to endoscopist’s 
judgement. Local TCA, 50 to 100 mg was injected into the 
submucosal layer of post-ESD ulcer margin using a 21-gauge 
needle. 
5. Statistical analysis
Statistical tests to compare the results included Student t-
test, chi-square test, Fisher exact test, and multivariate analysis. 
Mann-Whitney test was done for the nonparametric variable. 
A p<0.05 was considered statistically significant. All statistical 
analyses were performed using SPSS version 18.0 for Windows 
(SPSS Inc., Chicago, IL, USA).
RESULTS
1. Baseline characteristics and clinical factors associated 
with pyloric stricture after ESD 
The baseline characteristics of the study population are sum-
marized in Table 1. The median age of patients was 69.6 years, 
and the male/female ratio was 2.49:1 (107/43). The median age, 
ratio of sex, concomitant disease (hypertension, diabetes mel-
litus, chronic kidney disease, or hepatitis), location of lesions 
and the macroscopic type of the lesion were not significantly 
different between the two groups. A total of 103 patients had 
undergone ESD for gastric adenoma, and 47 patients for EGC. 
There were no significantly differences in histological find-
ings and depth of invasion between the two groups. En-bloc 
resection rate and curative resection rate was not significantly 
different between two groups. Among acute complications, the 
rate of post-ESD bleeding was higher in stricture group (2.9% 
vs 27.3%, p=0.009). Factor associated with ESD procedure was 
summarized in Table 2. Type of antral deformity and resection 
range if the pyloric ring was included were not significantly 
different between the two groups. Significant differences in the 
presence of pretreatment antral or pyloric deformity (46.8% 
vs 81.8%), proportion of extension to the circumference of the 
lumen (<3/4, 90.1% vs 45.5%; ≥3/4, 9.4% vs 54.5%) and longi-
tudinal extent of mucosal defect (27.9±10.1 mm vs 51.5±10.8 
mm) were found between the nonstricture and stricture groups, 
respectively.
2. Risk factors for endoscopic dilatation
All 11 patients who developed post-ESD stricture underwent 
successful endoscopic balloon dilatation without complications. 
The clinical characteristics of these patients are summarized 
in Table 3. Of these 11 patients, nine had an antral or pyloric 
deformity before ESD. Eight patients had antral or pyloric de-
formity of distortion dominant type and one patient had that 
of narrowing dominant type. The mean period from ESD to di-
agnosis of post-ESD stricture was 58.3±31.4 days (range, 29 to 
124 days). The median number of balloon dilatations used was 
2.0 (range, 1 to 4). Balloon size during dilatation ranged from 
13.5 mm to 20 mm. All patients experienced relief of obstruc-
tive symptoms (i.e., nausea, vomiting, and dysphagia) after the 
procedure and required no further treatment.
Risk factors for post-ESD stricture were then analyzed. In the 
univariate analysis, the proportion of post-ESD bleeding, antral 
or pyloric deformity, the larger longitudinal extent of mucosal 
defect and a circumferential extension to the mucosal defect of 
≥3/4 in stricture group were significantly higher than the cor-
responding parameters in the nonstricture group. Multivariate 
analysis revealed that pretreatment antral or pyloric deformity 
Table 2. Factors Associated with ESD Procedures
Variable Total (n=150)
Post-ESD stricture
p-value
None (n=139) Present (n=11)
Antral deformity 74 (49.3) 65 (46.8) 9 (81.8) 0.025
Type of antral deformity 0.665
    Distortion dominant 66 (89.2) 58 (87.9) 8 (88.9)
    Narrowing dominant 6 (8.1) 5 (7.7) 1 (11.1)
    Mixed type 2 (2.7) 2 (3.1) 0
Longitudinal extent of mucosal defect, mm 29.7±11.8 27.9±10.1 51.5±10.8 <0.001
Circumferential extent of mucosal defect 0.001
    ≥3/4 19 (12.7) 13 (9.4) 6 (54.5)
    <3/4 131 (87.3) 126 (90.1) 5 (45.5)
Resection included pyloric ring 0.249
    Yes 32 (21.3) 28 (20.0) 4 (36.4) 
    No 118 (78.7) 111 (80.0) 7 (63.6) 
Data are presented as number (%) or mean±SD.
ESD, endoscopic submucosal dissection.
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(odds ratio [OR], 30.53; 95% confidence interval [CI], 1.476 to 
631.565; p=0.027), a larger longitudinal extent of mucosal de-
fect (OR, 1.20; 95% CI, 1.074 to 1.340; p=0.001), and circumfer-
ential extension of ≥3/4 (OR, 13.69; 95% CI, 1.583 to 118.387; 
p=0.017) were independent risk factors for post-ESD stricture 
(Table 4). 
DISCUSSION
ESD is established as a standard treatment in many patients 
with gastric tumors. ESD is minimally invasive, preserves post-
operative gastric function, and has an efficacy similar to that 
with surgery.1,2,9,10 Because of the expanded indications of EGC 
and technical improvements, the number of patients with gas-
tric neoplasms undergoing ESD is increasing.9-13 Accordingly, 
the number of resection-related complications such as massive 
bleeding, perforation, and stricture is also increasing.14,15 Al-
though the safety of ESD has been demonstrated, it is techni-
cally challenging and requires a well-trained endoscopist who 
must be aware of the incidence and risk factors of resection-
related complications. 
Post-ESD stricture is a delayed complication of the procedure 
and a second treatment may be needed if post-ESD stricture 
develops. Therefore, awareness of the risk factors for post-ESD 
stricture before ESD is important, and patients at increased risk 
should be followed up more closely following ESD. To the best 
of our knowledge, our study results are the first to show that 
antral or pyloric deformity is a risk factor for post-ESD stricture, 
as well as circumferential extension over 75%. 
Bleeding and perforation are the most common complications 
and tend to occur during or within 24 to 48 hours after ESD,14-16 
whereas post-ESD strictures occur after several weeks. Cases 
of bleeding and perforation after ESD have been reported, and 
treatment procedures such as endoscopic hemostasis for bleed-
ing and endoscopic clipping or surgical treatment for perfora-
tion are well accepted.14,15 However, there are relatively few 
reports about post-ESD stricture and its treatment.6,7,17,18 
The reported incidence of post-ESD stricture is 0.7% to 1.9%,14 
and the incidences of post-ESD stricture in the cardia and py-
lorus are 17% and 7%, respectively.6 A small number of case 
reports describing post-ESD stricture and treatment have been 
published,17,18 along with two previous studies on the risk factors 
for post-ESD stricture.6,7 Both previous investigations reported 
that a circumferential extension over 75% and a larger longi-
tudinal diameter were risk factors for development of post-ESD 
strictures.6,7 Coda et al.6 reported that a circumferential extent of 
Table 3. Clinical Characteristics of Patients Who Had Undergone Balloon Dilatation
Patients
Age/ 
sex
Antral/pyloric 
deformity
Type of antral/ 
pyloric deformity
Subcircumferential 
extension over 75%
Days before  
diagnosis of  
pyloric stricture 
No. of  
dilatations
Balloon  
size, mm
Complication
Further  
treatment
1 66/M Yes Narrowing No  85 1 13.5–14 No No
2 77/M Yes Distortion No  29 4 14–17.5 No No
3 75/M No - Yes  42 2 15–20 No No
4 63/M Yes Distortion Yes  40 1 18–20 No No
5 80/M Yes Distortion No 124 1 18 No No
6 77/M Yes Distortion No  30 1 18 No No
7 72/M Yes Distortion Yes  70 4 16.5–18 No No
8 71/M Yes Distortion Yes  29 4 18 No No
9 84/M Yes Distortion Yes  38 1 20 No No
10 71/M Yes Distortion No  62 3 18 No No
11 74/M No - Yes  92 1 20 No No
M, male.
Table 4. Multivariate Analysis of Risk Factors for Post-ESD Stricture
Factor OR 95% CI p-value
Age, yr  0.99 0.849–1.147 0.863
Antral/pyloric deformity 30.53  1.476–631.565 0.027
Longitudinal extent of mucosal defect, mm (mean±SD)  1.20 1.074–1.340 0.001
Circumferential extent of mucosal defect, >3/4 13.69  1.583–118.387 0.017
Post-ESD bleeding & additional APC  1.76  0.118–26.442 0.681
OR, odds ratio; CI, confidence interval; ESD, endoscopic submucosal dissection; APC, argon plasma coagulation.
762  Gut and Liver, Vol. 10, No. 5, September 2016
the mucosal defect over 75% or longitudinal extent greater than 
5 cm in length were both risk factors for post-ESD stricture in 
patients undergoing cardiac and pyloric resection. Izuka et al.7 
noted that a circumferential extent over 75% was a risk factor 
for post-ESD stricture in six cases. However, post-ESD stricture 
can occur frequently even if the circumferential extension is 
<75% with a longitudinal extent <5 cm, for example, in the 
presence of antral or pylorus deformity before ESD. 
The present study investigated the impact of antral or pyloric 
deformity on the development of post-ESD strictures. Similar 
to previous studies, we showed that a circumferential extension 
of ≥3/4 (OR, 13.69; 95% CI, 1.583 to 118.387; p=0.017) and a 
larger longitudinal extent of mucosal defect (OR, 1.20; 95% CI, 
1.074 to 1.340; p=0.001) were risk factors for post-ESD stricture. 
Moreover, antral or pyloric deformity prior to treatment (OR, 
30.53; 95% CI, 1.476 to 631.565; p=0.027) was also an indepen-
dent risk factor for post-ESD stricture. Among the 11 patients in 
the stricture group, nine (81.8%) had an antral or pyloric defor-
mity while two (18.2%) did not.
Antral or pyloric deformity such as narrowing and distortion 
is usually caused by peptic ulcer scarring.8,19 ESD can cause a 
large artificial ulcer with gastric deformities during the healing 
process. Because artificial ulcers caused by ESD are formed sud-
denly and are confined to the superficial layer, they are reported 
to decrease in size with adjacent regenerative mucosa during 
healing.18 In the presence of a gastric deformity before ESD, py-
loric stricture can worsen. Recognizing risk factors of post-ESD 
stricture before ESD is very important. Because endoscopist can 
perform local steroid injection into the artificial ulcer after ESD 
to prevent post-ESD stricture. In previous study, local injection 
of TCA into the large artificial ulcer following ESD may prevent 
post-ESD gastric deformity.20 Therefore, the endoscopist should 
be aware of the risk of post-ESD stricture in patients with antral 
or pyloric deformity. 
In our study, the rate of post-ESD bleeding was higher in 
stricture group compared with nonstricture group. Seven cases 
of post-ESD bleeding were treated by endoscopic hemostasis us-
ing argon plasma coagulation (Erbe Elektromedizin). Additional 
APC at post-ESD ulcer could damage a muscle layer of post-
ESD ulcer and pyloric stricture could worsen. However, in the 
multivariate analysis of risk factors for post-ESD stricture, post-
ESD bleeding and additional APC was not a significant risk 
factor. Further large, multicenter trials could be necessary about 
long term adverse events after post-ESD bleeding and additional 
treatments.
Balloon dilatation is effective in enlarging strictures that form 
after ER and at the site of anastomosis following esophagec-
tomy or gastrectomy.21 Balloon dilatation is also considered as 
standard treatment for benign strictures caused by pathologies 
such as corrosive esophagitis and peptic gastric outlet obstruc-
tion. As seen in the present series of cases, balloon dilatation is 
also an effective treatment for post-ESD stricture.6,7,22 A previous 
study reported on 14 cases of post-ESD stricture and outcomes 
of balloon dilatation compared with peptic strictures.18 Although 
the safety of balloon dilatation has been demonstrated, it can be 
associated with procedure-related complications such as mas-
sive bleeding and perforation. Severe stricture and fibrosis can 
also develop after ESD during the healing phase. The risk of 
perforation during balloon dilatation is related to the stricture 
and fibrosis of the stomach wall. To lower the risk of perfora-
tion, intervention should be carried out as soon as possible, 
before the appearance of severe fibrosis. This can be achieved 
by close monitoring of patients at higher risk during follow-up. 
Nonetheless, post-ESD stricture can recur even though balloon 
dilatation is successful, and repeat balloon dilatation is consid-
ered as standard treatment for recurrent cases. The coexistence 
of deformity and post-ESD scarring can lead to more severe 
fibrosis and stricture during healing. Consequently, endoscopists 
must be aware that patients with larger subcircumferential ex-
tension over 75%, a larger longitudinal extent of mucosal defect 
and/or antral or pyloric deformity are at greater risk for post-
ESD stricture. Such patients warrant close follow-up so that 
intervention can be performed as early as possible.
 Our study has several limitations. First, we could not analyze 
the efficacy of local steroid injection because of small number. 
In our study, only two patients underwent prophylactic local 
TCA infection 1 to 2 days after ESD. Second, the study was 
a retrospective analysis and had a relative small sample size. 
However, the ESD data were prospectively collected in our in-
stitute to minimize the chance of bias. Further multicenter trials 
could validate the results seen herein. 
In conclusion, this study found that the presence of antral or 
pyloric deformity is one of the important risk factors for post-
ESD stricture. Patients with deformities before ESD should be 
carefully followed up and treated by local steroid injection 
therapy or endoscopic balloon dilatation at an early stage to 
prevent post-ESD stricture.
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